Ref ID: 18429
Author:
Dana Shik, Ariel Munitz.
Author address:
Tel Aviv University, Microbiology and Human
Immunology, Tel Aviv, Ramat Aviv, IL
Full conference title:
European Respiratory Congress
Abstract:
Background: Paired-Immunoglobulin-like receptor B (PIR-B) is an immunoreceptor
tyrosine-based inhibitory motif-containing receptor expressed predominantly
by myeloid cells, which counter-regulates their function. Recent data report exaggerated
Th2 activation in response to Alum/OVA sensitization in Pirb-/- mice due
to impaired dendritic cell function. Yet, the role of PIR-B in experimental asthma,
a “œhallmark” Th2-disease, is unknown.
Objective: To define the role of PIR-B in experimental asthma.
Methods: Wild type (WT) and Pirb-/- mice were intranasally-challenged with Aspergillus
fumigatus (Af) extract (12mg/60ml/mouse, 6 challenges/2 weeks). PIR-B
expression in the lungs of WT mice was assessed using flow cytometry combining
various myeloid cell markers. BALF was assessed for total and differential cell
counts as well as cytokine (IFN-g, IL-13, IL-4, IL-5) and chemokine profiles
(CCL17, CCL22, CXCL9, CXCL10) (ELISA, qPCR).
Results: Expression of PIR-B mRNA was upregulated in the lungs of WT mice
following Af-challenge. Af-challenged WT mice displayed significant infiltration
of multiple PIR-B+ cells including eosinophils, neutrophils, macrophages and various
myeloid cell subsets. Unexpectedly, allergen-challenged Pirb-/- mice displayed
significantly increased lung lymphocyte and neutrophil accumulation compared
with WT mice. Pirb-/- mice exhibited decreased levels of IL-4 and IL-13, CCL17
and CCL22 compared with WT mice. Conversely, Pirb-/- mice demonstrated significantly
increased IFNg and IFNg-dependent chemokines, CXCL9 and CXCL10,
compared with WT mice.
Conclusions: These results demonstrate a crucial and unexpected role for PIR-B
governing Th2-responses in experimental asthma.
Abstract Number: OP4
Conference Year: 2011
Link to conference website: http://www.ers-education.org/ersMade/abstract_print_11/files/Abstract_book_2011.pdf
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a